137 related articles for article (PubMed ID: 37221639)
1. Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
Yang J; Hu X; Li Q; Huang RL
J Craniofac Surg; 2023 Jul-Aug 01; 34(5):e485-e488. PubMed ID: 37221639
[TBL] [Abstract][Full Text] [Related]
2. Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
Li D; Sun F
Biomed Res Int; 2021; 2021():9514279. PubMed ID: 33791385
[TBL] [Abstract][Full Text] [Related]
3. A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease.
Kazim M; Gold KG
Curr Opin Ophthalmol; 2011 Sep; 22(5):391-3. PubMed ID: 21730842
[TBL] [Abstract][Full Text] [Related]
4. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage.
Costa PG; Saraiva FP; Pereira IC; Monteiro ML; Matayoshi S
Eye (Lond); 2009 Apr; 23(4):767-73. PubMed ID: 18535592
[TBL] [Abstract][Full Text] [Related]
6. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.
Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823
[TBL] [Abstract][Full Text] [Related]
7. Botox-A improve the thyroid-associated ophthalmopathy (TAO) orbital fibroblast activation through inhibiting the TGF-β/Smad signaling.
Qi X; Luo B; Deng M; Cao J; Hou S; Xie Z; Tong B; Xiong W
Exp Eye Res; 2022 Apr; 217():108971. PubMed ID: 35108585
[TBL] [Abstract][Full Text] [Related]
8. [Morphometric analysis of the palpebral fissure in patients with thyroid-related disfunction before and after application of botulinum toxin].
Costa PG; Saraiva FP; Matayoshi S
Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):920-5. PubMed ID: 17160217
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction].
Wabbels B; Förl M
Ophthalmologe; 2007 Sep; 104(9):771-6. PubMed ID: 17823804
[TBL] [Abstract][Full Text] [Related]
10. Nylon Hang Back Sutures in the Repair of Secondary Ptosis Following Overcorrected Dysthyroid Upper Eyelid Retraction.
Shah-Desai S; Azarbod P; Szamocki S; Rose GE
Ophthalmic Plast Reconstr Surg; 2016; 32(1):61-4. PubMed ID: 26505232
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type a for dysthyroid upper eyelid retraction.
Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.
Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A
Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553
[TBL] [Abstract][Full Text] [Related]
13. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study.
Träisk F; Tallstedt L
Acta Ophthalmol Scand; 2001 Dec; 79(6):585-8. PubMed ID: 11782224
[TBL] [Abstract][Full Text] [Related]
14. Levator Muscle Enlargement in Thyroid Eye Disease-Related Upper Eyelid Retraction.
Davies MJ; Dolman PJ
Ophthalmic Plast Reconstr Surg; 2017; 33(1):35-39. PubMed ID: 26808176
[TBL] [Abstract][Full Text] [Related]
15. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
Choi SW; Lee JY; Lew H
Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
[TBL] [Abstract][Full Text] [Related]
16. Lower eyelid epiblepharon associated with lower eyelid retraction.
Sung MS; Lee MJ; Choung HK; Kim NJ; Khwarg SI
Korean J Ophthalmol; 2010 Feb; 24(1):4-9. PubMed ID: 20157407
[TBL] [Abstract][Full Text] [Related]
17. An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results.
Ozturk Karabulut G; Fazil K; Saracoglu Yilmaz B; Ozturker C; Günaydın ZK; Taskapili M; Kaynak P
Orbit; 2021 Oct; 40(5):381-388. PubMed ID: 32885692
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
Ma R; Cheng Y; Gan L; Zhou X; Qian J
BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
[TBL] [Abstract][Full Text] [Related]
19. Results of surgical correction of upper eyelid retraction in Graves' Orbitopathy.
Pinas D; O B De Keizer R; Wubbels RJ; van den Bosch WA; Paridaens D
Acta Ophthalmol; 2021 Jun; 99(4):e608-e613. PubMed ID: 32930505
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of various surgical procedures on acquired lower eyelid epiblepharon in thyroid associated ophthalmopathy.
Park SW; Kim N; Choung HK; Khwarg SI
Korean J Ophthalmol; 2012 Oct; 26(5):319-23. PubMed ID: 23060717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
